Neurology Minute podcast

A Path to Preventing Cognitive Impairment Due to Alzheimer's Disease

0:00
2:02
Spola tillbaka 15 sekunder
Spola framåt 15 sekunder

Dr. Greg Cooper and Dr. Eric Reiman discuss emerging antibody therapies for preclinical Alzheimer's disease and the clinical, regulatory, and equity considerations shaping prevention trials and future care.

Show citation: 

Reiman EM, Alexander RC, Langbaum JB, et al. A path to preventing cognitive impairment due to Alzheimer's disease: initiatives beginning in the USA. Lancet Neurol. 2026;25(3):268-278. doi:10.1016/S1474-4422(25)00483-1 

Fler avsnitt från "Neurology Minute"